A functional variant at miR-24 binding site in B7-H2 alters susceptibility to gastric cancer in a Chinese Han population

Molecular Immunology

Volumn 56, Issue 1-2, 2013, Pages 98-103

  Yang, Panpan ^a,b   Tang, Rong ^b   Zhu, Jianjie ^b   Zou, Lingting ^c   Wu, Ruirong ^a   Zhou, Huan ^a   Mao, Yong ^a   Li, Rui ^c   Hua, Dong ^a   Wang, Weipeng ^b   Zhang, Hongjian ^b  

^a Soochow University   (China)

^b SOOCHOW UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B7 H2; Gastric cancer; MiR 24; Single nucleotide polymorphism

Indexed keywords

INDUCIBLE T CELL COSTIMULATOR LIGAND; MICRORNA 24;

3' UNTRANSLATED REGION; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

3' UNTRANSLATED REGIONS; ALLELES; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BINDING SITES; CHINA; CHO CELLS; CRICETINAE; CRICETULUS; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; LOGISTIC MODELS; MICRORNAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84879069041     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.04.010     Document Type: Article

References (27)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., Muller R.U., Straka E., Su L., Burki E.A., Crowell R.E., Patel R., Kulkarni T., Homer R., Zelterman D., Kidd K.K., Zhu Y., Christiani D.C., Belinsky S.A., Slack F.J., Weidhaas J.B. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Research 2008, 68:8535-8540.
3. Christensen B.C., Moyer B.J., Avissar M., Ouellet L.G., Plaza S.L., McClean M.D., Marsit C.J., Kelsey K.T. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009, 30:1003-1007.
4. Gibcus J.H., Tan L.P., Harms G., Schakel R.N., de Jong D., Blokzijl T., Moller P., Poppema S., Kroesen B.J., van den Berg A. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009, 11:167-176.
5. Jazdzewski K., Liyanarachchi S., Swierniak M., Pachucki J., Ringel M.D., Jarzab B., de la Chapelle A. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1502-1505.
6. Landi D., Gemignani F., Naccarati A., Pardini B., Vodicka P., Vodickova L., Novotny J., Forsti A., Hemminki K., Canzian F., Landi S. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008, 29:579-584.
7. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
8. Lin S.C., Liu C.J., Lin J.A., Chiang W.F., Hung P.S., Chang K.W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncology 2010, 46:204-208.
9. Mishra P.J., Humeniuk R., Mishra P.J., Longo-Sorbello G.S., Banerjee D., Bertino J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13513-13518.
10. Mishra P.J., Song B., Mishra P.J., Wang Y., Humeniuk R., Banerjee D., Merlino G., Ju J., Bertino J.R. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS ONE 2009, 4:e8445.
11. Nicoloso M.S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S.E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C.M., Davuluri R.V., Calin G.A. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Research 2010, 70:2789-2798.
12. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005, 55:74-108.
13. Qin W., Shi Y., Zhao B., Yao C., Jin L., Ma J., Jin Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS ONE 2010, 5:e9429.
14. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nature Reviews Cancer 2010, 10:389-402.
15. Saetrom P., Biesinger J., Li S.M., Smith D., Thomas L.F., Majzoub K., Rivas G.E., Alluin J., Rossi J.J., Krontiris T.G., Weitzel J., Daly M.B., Benson A.B., Kirkwood J.M., O'Dwyer P.J., Sutphen R., Stewart J.A., Johnson D., Larson G.P. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Research 2009, 69:7459-7465.
16. Sun L., Yao Y., Liu B., Lin Z., Lin L., Yang M., Zhang W., Chen W., Pan C., Liu Q., Song E., Li J. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012, 31:432-445.
17. Tamura H., Dan K., Tamada K., Nakamura K., Shioi Y., Hyodo H., Wang S.D., Dong H., Chen L., Ogata K. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clinical Cancer Research 2005, 11:5708-5717.
18. To K.H., Pajovic S., Gallie B.L., Theriault B.L. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development. BMC Cancer 2012, 12:69.
19. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., Hijiya N., Matsuura K., Fujioka T., Seto M., Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Research 2010, 70:2339-2349.
20. Wang Q., Huang Z., Xue H., Jin C., Ju X.L., Han J.D., Chen Y.G. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008, 111:588-595.
21. Wang S., Zhu G., Chapoval A.I., Dong H., Tamada K., Ni J., Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000, 96:2808-2813.
22. Wang W., Li F., Mao Y., Zhou H., Sun J., Li R., Liu C., Chen W., Hua D., Zhang X. A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma. Human Genetics 2013, in press.
23. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., Zheng Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 2008, 3:e2557.
24. Wu J., Zhang Y.C., Suo W.H., Liu X.B., Shen W.W., Tian H., Fu G.H. Induction of anion exchanger-1 translation and its opposite roles in the carcinogenesis of gastric cancer cells and differentiation of K562 cells. Oncogene 2010, 29:1987-1996.
25. Xie Y., Tobin L.A., Camps J., Wangsa D., Yang J., Rao M., Witasp E., Awad K.S., Yoo N., Ried T., Kwong K.F. MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene 2012, in press.
26. Yang H., Kong W., He L., Zhao J.J., O'Donnell J.D., Wang J., Wenham R.M., Coppola D., Kruk P.A., Nicosia S.V., Cheng J.Q. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 2008, 68:425-433.
27. Zou W., Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nature Reviews Immunology 2008, 8:467-477.